当前位置:主页 > 医学论文 > 急救学论文 >

中药升降散干预脓毒症免疫功能紊乱的临床疗效及其可能机制探讨

发布时间:2018-02-12 11:33

  本文关键词: 脓毒症 免疫功能 升降散 临床疗效 出处:《免疫学杂志》2017年11期  论文类型:期刊论文


【摘要】:目的评估中药升降散对纠正脓毒症免疫功能紊乱和改善患者症状的临床疗效。方法选取2014年6月至2016年6月在宁夏回族自治区工人医院就诊的53例脓毒症患者作为研究对象,根据住院号的奇偶性分为观察组(n=28)和对照组(n=25)。2组均予以西医常规治疗,观察组在此基础上加用升降散治疗,对照组则相应给予生理盐水。观察2组在治疗后第1、3和7天的免疫指标变化和记录28天内的临床结局。结果与对照组相比,观察组患者在给药第7天时的CD4~+T细胞计数、CD8~+T细胞计数和m HLADR表达显著增加(P0.05)。进一步评估单核细胞功能结果显示,与对照组相比,观察组患者在给药第3天和第7天的单核细胞分泌的IL-6和TNF-α水平显著提高(P0.05),而在第7天的IL-10水平显著降低(P0.05)。观察组患者的ICU住院时间、APACHE II评分、Marshall评分和血管加压素使用时间均显著低于对照组(P0.05)。结论升降散可以纠正脓毒症患者的细胞免疫,并且可作为一个有希望的脓毒症辅助治疗方案。
[Abstract]:Objective to evaluate the clinical effect of Shengsheng Powder on correcting the immune dysfunction and improving the symptoms of sepsis. Methods 53 patients with sepsis were selected from June 2014 to June 2016 in the workers' hospital of Ningxia Hui Autonomous region. According to the parity of hospital number, the patients in the observation group were divided into two groups: the observation group and the control group were treated with routine western medicine. The control group was given normal saline accordingly. The changes of immune indexes and clinical outcome within 28 days after treatment were observed and compared with those in the control group. The CD4 ~ T cell count and the expression of m HLADR were significantly increased in the observation group on the 7th day after administration. Further evaluation of monocyte function showed that compared with the control group, the expression of m HLADR and CD8T cell were significantly increased in the observation group. The levels of IL-6 and TNF- 伪 secreted by monocytes on the 3rd and 7th day of administration in the observation group were significantly higher than those in the control group, while the level of IL-10 was significantly decreased on the 7th day. The ICU hospitalization time of the patients in the observation group was evaluated by Apache II score and vascular pressure. Conclusion Shengsheng Powder can correct the cellular immunity of sepsis patients. It can be used as a promising adjuvant therapy for sepsis.
【作者单位】: 宁夏回族自治区工人疗养院普外科;天津市人民医院科普外科;
【分类号】:R459.7

【相似文献】

相关期刊论文 前10条

1 李武祥,袁丽华,李利明,钟岩,张宏宇;多种装璜材料燃烧所致伤害与脓毒症的临床研究[J];黑龙江医药科学;2000年02期

2 刘学英;魏艳苏;李兰凤;任志萍;;小儿脓毒症28例观察及护理[J];河北医药;2008年04期

3 袁志强,彭毅志;新的肾透疗法防治脓毒症[J];中华烧伤杂志;2000年02期

4 孙成栋;张淑文;董军;;脓毒症临床实验免疫指标研究进展[J];中国危重病急救医学;2005年12期

5 张连阳;;脓毒症治疗有哪些进展?[J];创伤外科杂志;2007年01期

6 刘明伟;苏美仙;黄青青;;脓毒症的免疫抑制及治疗策略[J];中国全科医学;2007年08期

7 王玉红;周荣斌;;拮抗肾素-血管紧张素-醛固酮系统可能成为治疗脓毒症的新策略[J];临床急诊杂志;2011年04期

8 丁榆;李杏崧;;重度脓毒症引起严重血小板减少患者的护理[J];当代护士(专科版);2011年10期

9 董红岩;陈圆圆;;脓毒症88例的护理[J];中国误诊学杂志;2012年02期

10 王正国;;当前脓毒症研究的思考[J];解放军医学杂志;2012年11期

相关会议论文 前10条

1 张振辉;陈晓辉;林s钜,

本文编号:1505536


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/jjyx/1505536.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户03afe***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com